ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Cyclerion Therapeutics and Beacon Biosignals Announce Expanded Strategic Partnership
July 09, 2021Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two companies. -
Cyclerion Announces Sickle Cell Disease Study Results
October 22, 2020Cyclerion Therapeutics announced top-line results from its STRONG-SCD study of olinciguat, an investigational, orally-administered, once daily, vascular sGC stimulator for the potential treatment of sickle cell disease (SCD). -
Cyclerion Announces Positive Data from CNS Translational Study in Healthy Elderly Subjects
October 21, 2020Cyclerion Therapeutics announced results from its Phase 1 translational pharmacology study of IW-6463, the first soluble guanylate cyclase (sGC) stimulator in clinical development for CNS disorders.
Pharma Sources Insight January 2025
